Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Dadeli Pharmaceutical is a comprehensive pharmaceutical enterprise located in the Lanzhou High-tech Industrial Development Zone in Gansu Province, China. Established in 1998, the company specializes in the research, development, and large-scale production of various pharmaceutical dosage forms, including large and small volume injections, tablets, capsules, and granules. Its core product offerings include Compound Glycyrrhizin injections for liver diseases and a variety of essential intravenous infusions and anti-infective medications. The company maintains multiple GMP-certified production lines and is recognized as a key provincial-level high-tech enterprise. Dadeli Pharmaceutical plays a significant role in the regional healthcare supply chain, providing essential medicines to hospitals and clinics across Northwest China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Dadeli Pharmaceutical.